Home

Melanotan II research examines a synthetic melanocortin analogue with activity across receptor systems. It is often confused with Melanotan I in online discussions, even though they are distinct molecules with…

Melanotan I research explores a synthetic melanocortin analogue and receptor biology related to pigmentation. Published work on specific compounds must be distinguished from online products with similar names. This guide…

AOD-9604 research focuses on a peptide fragment derived from a region of human growth hormone. The proposed biological rationale has been examined in laboratory and animal models, with human research…

CJC-1295 with DAC research examines a synthetic growth-hormone-releasing hormone analogue modified with a drug-affinity complex. The modification was designed to promote reversible albumin binding and extend exposure. Molecular design explains…

survodutide research examines a dual agonist designed to engage glucagon and GLP-1 receptors. Researchers study how this pharmacology relates to measured outcomes in carefully defined clinical trials. The receptor concept…

Cagrilintide research examines a long-acting amylin analogue and its effects in controlled clinical studies. Amylin is a hormone involved in appetite and post-meal physiology. A mechanism can motivate a trial,…

CagriSema research examines cagrilintide, an amylin analogue, in combination with semaglutide, a GLP-1 receptor agonist. Researchers ask whether the two distinct pathways, studied together, change measured outcomes compared with the…